Status:
COMPLETED
Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Aarhus University Hospital
Conditions:
Acromegaly
Excessive Growth Hormone Secretion
Eligibility:
All Genders
18-70 years
Brief Summary
The purpose of this study is to investigate the effects of chronic elevated growth hormone on metabolism and insulin sensitivity by studying acromegalic patients before and after treatment.
Eligibility Criteria
Inclusion
- Written consent
- Age between 18 and 70
- Recently diagnosed with acromegaly
Exclusion
- NYHA 3
- Uncontrolled hypertension
- Known cerebrovascular disease
- Proliferative retinopatia
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 7 2016
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00647179
Start Date
February 1 2008
End Date
December 7 2016
Last Update
December 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Endocrinology, Aarhus University Hospital
Aarhus C, Aarhus, Denmark, DK-8000